MétaCan
Menu
Back to cohort
Record W2961765674 · doi:10.1111/tid.13145

Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study

2019· article· en· W2961765674 on OpenAlexaff
Seema Naik, Marcie Riches, Parameswaran Hari, Soyoung Kim, Min Chen, Carlos Bachier, Paul Shaughnessy, Joshua A. Hill, Per Ljungman, Minoo Battiwalla, Saurabh Chhabra, Andrew Daly, Jan Storek, Celalettin Üstün, Miguel Ángel Díaz, Jan Černý, Amer Beitinjaneh, Jean A. Yared, Valerie I. Brown, Kristin Page, Parastoo B. Dahi, Siddhartha Ganguly, Sachiko Seo, Nelson J. Chao, César O. Freytes, Ayman Saad, Bipin N. Savani, Kwang Woo Ahn, Michael Boeckh, Helen E. Heslop, Hillard M. Lazarus, Jeffery J. Auletta, Rammurti T. Kamble

Bibliographic record

VenueTransplant Infectious Disease · 2019
Typearticle
Languageen
FieldMedicine
TopicViral-associated cancers and disorders
Canadian institutionsUniversity of Calgary
FundersNational Cancer InstituteNational Institutes of Health
KeywordsMedicinePost-transplant lymphoproliferative disorderHematopoietic cellLymphoproliferative disordersImmunologyHematopoietic stem cell transplantationYoung adultEpstein–Barr virusTransplantationLymphomaHaematopoiesisStem cellVirusInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background Post‐transplant lymphoproliferative disorders (PTLD) are associated with significant morbidity and mortality following allogeneic hematopoietic cell transplant (alloHCT). Although most PTLD is EBV‐positive (EBV pos ), EBV‐negative (EBV neg ) PTLD is reported, yet its incidence and clinical impact remain largely undefined. Furthermore, factors at the time of transplant impacting survival following PTLD are not well described. Methods Between 2002 and 2014, 432 cases of PTLD following alloHCT were reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). After exclusions, 267 cases (EBV pos = 222, 83%; EBV neg = 45, 17%) were analyzed. Results Two hundred and eight patients (78%) received in vivo T‐cell depletion (TCD) with either anti‐thymocyte globulin (ATG) or alemtuzumab. Incidence of PTLD was highest using umbilical cord donors (UCB, 1.60%) and lowest using matched related donors (MRD, 0.40%). Clinical features and histology did not significantly differ among EBV pos or EBV neg PTLD cases except that absolute lymphocyte count recovery was slower, and CMV reactivation was later in EBV neg PTLD [EBV pos 32 (5‐95) days versus EBV neg 47 (10‐70) days, P = .016]. There was no impact on survival by EBV status in multivariable analysis [EBV neg RR 1.42, 95% CI 0.94‐2.15, P = .097]. Conclusions There is no difference in survival outcomes for patients with EBV pos or EBV neg PTLD occurring following alloHCT and 1‐year survival is poor. Features of conditioning and use of serotherapy remain important.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.021
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.241
Teacher spread0.233 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations27
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueTransplant Infectious DiseaseSame topicViral-associated cancers and disordersFrench-language works237,207